AstraZeneca Vaccine 79% Efficacious in Phase 3 Interim Results AstraZeneca Vaccine 79% Efficacious in Phase 3 Interim Results

The company plans to file for emergency use authorization from the FDA in the first half of April.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news